357 related articles for article (PubMed ID: 10785448)
1. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
2. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
[TBL] [Abstract][Full Text] [Related]
3. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
4. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
van de Nes JA; Sandmann-Keil D; Braak H
Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
[TBL] [Abstract][Full Text] [Related]
5. [Argyrophilic grain disease (AgD), a frequent and largely underestimated cause of dementia in old patients].
Probst A; Tolnay M
Rev Neurol (Paris); 2002 Feb; 158(2):155-65. PubMed ID: 11965171
[TBL] [Abstract][Full Text] [Related]
6. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
[TBL] [Abstract][Full Text] [Related]
7. Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition.
Giannakopoulos P; von Gunten A; Kövari E; Gold G; Herrmann FR; Hof PR; Bouras C
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):334-43. PubMed ID: 17442063
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
9. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct.
Strong C; Anderton BH; Perry RH; Perry EK; Ince PG; Lovestone S
Alzheimer Dis Assoc Disord; 1995; 9(4):218-22. PubMed ID: 8749611
[TBL] [Abstract][Full Text] [Related]
10. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
11. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
Brady DR; Mufson EJ
J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
[TBL] [Abstract][Full Text] [Related]
12. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation.
Su JH; Deng G; Cotman CW
Neurobiol Dis; 1997; 4(5):365-75. PubMed ID: 9440125
[TBL] [Abstract][Full Text] [Related]
13. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.
Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O
Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713
[TBL] [Abstract][Full Text] [Related]
14. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
15. Perforant pathway changes and the memory impairment of Alzheimer's disease.
Hyman BT; Van Hoesen GW; Kromer LJ; Damasio AR
Ann Neurol; 1986 Oct; 20(4):472-81. PubMed ID: 3789663
[TBL] [Abstract][Full Text] [Related]
16. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
17. Memory deficits in amyotrophic lateral sclerosis patients with dementia and degeneration of the perforant pathway A clinicopathological study.
Takeda T; Uchihara T; Mochizuki Y; Mizutani T; Iwata M
J Neurol Sci; 2007 Sep; 260(1-2):225-30. PubMed ID: 17561122
[TBL] [Abstract][Full Text] [Related]
18. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
[TBL] [Abstract][Full Text] [Related]
19. Parallel activation of field CA2 and dentate gyrus by synaptically elicited perforant path volleys.
Bartesaghi R; Gessi T
Hippocampus; 2004; 14(8):948-63. PubMed ID: 15390176
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
